Therefore, in tumor patients infected with SARS-CoV-2, the downregulation of ACE2 levels might cause an imbalance in the RAS system and activate the ACE-Ang II-AGTR1 axis, which would likely aggravate the clinical symptoms of tumor patients with heart disease and even induce heart failure. This evidence concerns the gene ACE2 and heart failure.